2 - TI Pharma

60. Opherk C, Tronche F, Kellendonk C, Kohlmuller D, Schulze A, Schmid W, Schutz G. Inactivation of the
glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia
in streptozotocin-induced diabetes mellitus. Mol Endocrinol. 2004;18(6):1346-53.
61. Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic
fatty liver disease. Gastroenterology. 2007;132(6):2191-207.
62. Giudetti AM, Gnoni GV. Short-term effect of dexamethasone on fatty acid and cholesterol synthesis
in isolated rat hepatocytes. Biochem Mol Biol Int. 1998;44(3):515-21.
63. Cole TG, Wilcox HG, Heimberg M. Effects of adrenalectomy and dexamethasone on hepatic lipid
metabolism. j Lipid Res. 1982;23(1):81-91.
64. Shteyer E, Liao Y, Muglia Lj, Hruz PW, Rudnick DA. Disruption of hepatic adipogenesis is associated
with impaired liver regeneration in mice. Hepatology. 2004;40(6):1322-32.
65. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson jP, Besser GM, Grossman AB, Reznek
RH. Hepatic steatosis in Cushing’s syndrome: a radiological assessment using computed tomography.
Eur j Endocrinol. 2003;149(6):543-8.
66. Itoh S, Igarashi M, Tsukada Y, Ichinoe A. Nonalcoholic fatty liver with alcoholic hyalin after long-term
glucocorticoid therapy. Acta Hepatogastroenterol (Stuttg). 1977;24(6):415-8.
67. Westerbacka j, Yki-jarvinen H, Vehkavaara S, Hakkinen AM, Andrew R, Wake Dj, Seckl jR, Walker
BR. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase
and lower cortisol/cortisone metabolite ratios in men with fatty liver. j Clin Endocrinol Metab.
2003;88(10):4924-31.
68. Ettinger WH, jr., Hazzard WR. Prednisone increases very low density lipoprotein and high density
lipoprotein in healthy men. Metabolism. 1988;37(11):1055-8.
69. Taskinen MR, Kuusi T, Yki-jarvinen H, Nikkila EA. Short-term effects of prednisone on serum lipids
and high density lipoprotein subfractions in normolipidemic healthy men. j Clin Endocrinol Metab.
1988;67(2):291-9.
70. Morton NM, Seckl jR. 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Front Horm Res.
2008;36:146-64.
71. Bjorntorp P. Visceral fat accumulation: the missing link between psychosocial factors and
cardiovascular disease? j Intern Med. 1991;230(3):195-201.
72. Whitworth jA, Williamson PM, Mangos G, Kelly jj. Cardiovascular consequences of cortisol excess.
Vasc Health Risk Manag. 2005;1(4):291-9.
73. Kershaw EE, Flier jS. Adipose tissue as an endocrine organ. j Clin Endocrinol Metab. 2004;89(6):2548-
56.
74. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia.
2003;46(12):1594-603.
45
2
Chapter 2